Results 11 to 20 of about 174,772 (308)

New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor.
Victor Pavan Pasin   +5 more
doaj   +1 more source

New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies [PDF]

open access: yesEncephalitis, 2021
In the literature, several adult cases with myelin oligodendrocyte glycoprotein (MOG) antibodies (Abs)-associated disorders have been reported to have seizure and acute disseminated encephalomyelitis (ADEM) as the main clinical manifestations, but the ...
Hansol Im, Taewon Kim
doaj   +1 more source

Efficacy and safety of immunosuppressive treatment in IgA nephropathy: a meta-analysis of randomized controlled trials

open access: yesBMC Nephrology, 2019
Background Immunosuppressive agents have been widely used in the treatment of IgA nephropathy (IgAN), but the efficacy and safety remain controversial.
Zheng Zhang   +3 more
doaj   +1 more source

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2014
The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used.
Stephanie Del Rio Navarrete Biot   +5 more
doaj   +1 more source

Off-label use of rituximab in dermatology: pemphigus treatment [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2013
Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis.
Lislaine Bomm   +4 more
doaj   +1 more source

Statins as immunosuppressive agents [PDF]

open access: yesLiver Transplantation, 2001
Abstract Unavailable. Please See Print Journal.
openaire   +3 more sources

Infiltrative cardiomyopathies. Report of a case of cardiac sarcoidosis

open access: yesIatreia, 2017
Sarcoidosis is characterized by the presence of non-caseating granulomas that may affect any organ. Heart involvement manifests as cardiomyopathy. Frequency of cardiac involvement in sarcoidosis is around 30 %, but only 5 % of such cases are symptomatic.
Muñoz-Ortiz, Édison   +3 more
doaj   +1 more source

Rituximab: A Magic Bullet for Pemphigus [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Pemphigus, an autoimmune disease, was fatal before the era of corticosteroids. With the advent of steroids, mortality decreased but morbidity was present due to the side effects of high dose steroids.
V. Anandan   +4 more
doaj   +1 more source

New immunosuppressive agents in pediatric transplantation

open access: yesClinics, 2014
Immunosuppressive therapy in pediatrics continues to evolve. Over the past decade, newer immunosuppressive agents have been introduced into adult and pediatric transplant patients with the goal of improving patient and allograft survival.
Christina Nguyen, Ron Shapiro
doaj   +1 more source

Nonimmunologic targets of immunosuppressive agents in podocytes

open access: yesKidney Research and Clinical Practice, 2015
Proteinuria is a characteristic finding in glomerular diseases and is closely associated with renal outcomes. In addition, therapeutic interventions that reduce proteinuria improve renal prognosis.
Tae-Hyun Yoo, Alessia Fornoni
doaj   +1 more source

Home - About - Disclaimer - Privacy